Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC DW71177 | 2241311-72-6 | 97.7% | 384.48 | 50 MG
SDP

Catalog No. 5000394959
Encompass_Preferred

DW71177 is a novel triazolo[4,3-a] quinoxaline-based potent and BD1-Selective BET inhibitor. It can be used for the study of acute myeloid leukemia.

  • Novel triazolo[4,3-a] quinoxaline-based compound
  • Potent and BD1-selective BET inhibitor
  • Can be used for the study of acute myeloid leukemia

Catalog No. 50-003-94959 Supplier Medchemexpress LLC Supplier No. HY16208850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DW71177 is a novel triazolo[4,3-a] quinoxaline-based potent and BD1-Selective BET inhibitor. It can be used for the study of acute myeloid leukemia.

  • Novel triazolo[4,3-a] quinoxaline-based compound
  • Potent and BD1-selective BET inhibitor
  • Can be used for the study of acute myeloid leukemia

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.